scholarly journals The oophorectomy effect on Walker 256 tumor inoculated into the vagina and uterine cervix of female rats

2009 ◽  
Vol 24 (1) ◽  
pp. 26-29 ◽  
Author(s):  
Nara Macedo Botelho Brito ◽  
Rita de Kássia Vidigal Carvalho ◽  
Lia Tavares de Moura Brasil Matos ◽  
Rodolfo Costa Lobato ◽  
Rosângela Baía Brito

PURPOSE: Verify the effect of oophorectomy on the evolution of the Walker 256 tumor inoculated into the vagina and cervix of female rats. METHODS: Ten Wistar, female rats were used, distributed into two groups with 05 animals each: Tumor group (TG): Rats inoculated with Walker 256 tumor; Oophorectomy group (OG): oophorectomized rats inoculated with Walker 256 tumor. The day before the tumor vaginal inoculation, acetic acid was inoculated into the vaginas of both groups of rats; the following day, the vaginal walls were scarified with an endocervix brush, and then Walker 256 tumor was inoculated. After 12 days, the tumor was removed together with the vagina and uterine horns for macro and microscopic analyses. The data were submitted to statistical analyses. RESULTS: There was no statistical difference between the two groups; however it was observed that the behavior of tumor growth on the OG group presented greater invasion, compromising the uterine horns. CONCLUSION: The results of the study on the GO group presented a macroscopic behavior different from the TG group, however, both of them presented similar development in terms of tumor mass.

2010 ◽  
Vol 25 (2) ◽  
pp. 176-180 ◽  
Author(s):  
Nara Macedo Botelho Brito ◽  
Marcus Vinicius Henriques Brito ◽  
Rita de Kássia Vidigal Carvalho ◽  
Lia Tavares de Moura Brasil Matos ◽  
Rodolfo Costa Lobato ◽  
...  

PURPOSE: To verify the copaiba balsam (Copaifera officinalis) effect on Walker 256 carcinoma inoculated into vagina and uterine cervix of rats. METHODS: Eighteen female Wistar rats weighing between 180-250g were used, distributed into 2 groups (GCop, GC). On the 1st day of the experiment, 0.3 ml of Walker 256 carcinoma (2x10(6) concentration) was inoculated in both groups; on the 3rd day of the experiment, it was given 4.8 ml/kg of distilled water to the GC group, and 4.8 ml/kg of copaiba balsam to the GCop group. On the 12th day, euthanasia was performed and the tumor was grafted, being weighted and verified its volume. The data were submitted to statistical analysis with ANOVA test. RESULTS: It was observed that copaiba balsam presented a negative inhibitory potential of 70%. CONCLUSION: The copaiba balsam stimulated the tumor growth.


1995 ◽  
Vol 81 (5) ◽  
pp. 370-377 ◽  
Author(s):  
Ovidio Rettori ◽  
Ana Neuza Vieira-Matos ◽  
Quivo S. Tahin

Cancer pathognomonic systemic effects (PSE) have high individual variability. For this reason present data were collected daily and synchronized considering four main points: inoculation day, onset of PSE, aggravation and death. The subclinical period free of PSE ranged between 15.7±2.2 days, the clinical period was less variable, 8.9±0.5 days, divided in a moderate and a grave phase of nearly the same length. PSE involved disturbances of fundamental homeostatic regulations: appetite, sodium, water, immune, etc. PSE triggering correlated highly with survival (r2=0.95, P<0.01), but poorly with primary tumor growth, and it was anticipated by metastases from 20.5±2.6 to 10.6±1.1 days (P<0.01). After multifocal simultaneous inoculations, PSE triggering was anticipated to 4.2±0.2 days (marked reduction of individual variability), in the presence of small total-tumor masses, absence of macroscopic metastases, and without changes in the following clinical period features. PSE triggering seems to be a major prognostic indicator probably related to multifocal tumor growth.


2015 ◽  
Vol 67 (5) ◽  
pp. 839-846 ◽  
Author(s):  
Dalton Luiz Schiessel ◽  
Ricardo K. Yamazaki ◽  
Marcelo Kryczyk ◽  
Isabela Coelho ◽  
Adriana A. Yamaguchi ◽  
...  

2019 ◽  
Vol 17 (2) ◽  
Author(s):  
Camila de Carvalho Juanes ◽  
Susana Moreira de Souza ◽  
Vanessa Nogueira Lages Braga ◽  
Francisco Stefânio Barreto ◽  
Gisele Rocha Aguiar ◽  
...  

Nutrition ◽  
2020 ◽  
Vol 79-80 ◽  
pp. 110958
Author(s):  
Paola Sanches Cella ◽  
Poliana C. Marinello ◽  
Camila S. Padilha ◽  
Mayra T. Testa ◽  
Philippe B. Guirro ◽  
...  

2013 ◽  
Vol 46 (8) ◽  
pp. 696-699 ◽  
Author(s):  
G. Borghetti ◽  
R.K. Yamazaki ◽  
I. Coelho ◽  
D.C.T. Pequito ◽  
D.L. Schiessel ◽  
...  

2016 ◽  
Vol 2016 ◽  
pp. 1-11 ◽  
Author(s):  
Patrícia Brigatte ◽  
Odair Jorge Faiad ◽  
Roberta Cornélio Ferreira Nocelli ◽  
Richardt G. Landgraf ◽  
Mario Sergio Palma ◽  
...  

We investigated the effects of Crotoxin (CTX), the main toxin of South American rattlesnake (Crotalus durissus terrificus) venom, on Walker 256 tumor growth, the pain symptoms associated (hyperalgesia and allodynia), and participation of endogenous lipoxin A4. Treatment with CTX (s.c.), daily, for 5 days reduced tumor growth at the 5th day after injection of Walker 256 carcinoma cells into the plantar surface of adult rat hind paw. This observation was associated with inhibition of new blood vessel formation and decrease in blood vessel diameter. The treatment with CTX raised plasma concentrations of lipoxin A4and its natural analogue 15-epi-LXA4, an effect mediated by formyl peptide receptors (FPRs). In fact, the treatment with Boc-2, an inhibitor of FPRs, abolished the increase in plasma levels of these mediators triggered by CTX. The blockage of these receptors also abolished the inhibitory action of CTX on tumor growth and blood vessel formation and the decrease in blood vessel diameter. Together, the results herein presented demonstrate that CTX increases plasma concentrations of lipoxin A4and 15-epi-LXA4, which might inhibit both tumor growth and formation of new vessels via FPRs.


2003 ◽  
Vol 46 (1) ◽  
pp. 52-58 ◽  
Author(s):  
Valeria Togni ◽  
Claudia C. C. Ota ◽  
Alessandra Folador ◽  
O. Tchaikovski Junior ◽  
Julia Aikawa ◽  
...  

2005 ◽  
Vol 53 (2) ◽  
pp. 194-201 ◽  
Author(s):  
Nathalia Pizato ◽  
Sandro Bonatto ◽  
Ricardo K. Yamazaki ◽  
Julia Aikawa ◽  
Claudia Nogata ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document